|
End-of-day quote
Thailand S.E.
2026-11-02
|
5-day change | 1st Jan Change | ||
| 9.900 THB | -1.98% |
|
+2.06% | +35.62% |
| 11-02 | Galderma Finance Chief to Step Down, Months After Joining Company | DJ |
| 11-02 | Canaccord Genuity Adjusts Price Target on AbbVie to $338 From $290 | MT |
Chart calendar AbbVie Inc.
Upcoming events on AbbVie Inc.
No events available
Past events on AbbVie Inc.
| 2026-10-30 | Earnings release - Q3 2026 | |
| 2026-10-30 | Earnings presentation | 09:00 |
| 2026-07-31 | Earnings presentation | 09:00 |
| 2026-07-31 | Earnings release - Q2 2026 | |
| 2026-05-08 | Présentation aux Actionnaires / Analystes | 10:00 |
| 2026-05-08 | Annual General Meeting | 10:00 |
| 2026-04-29 | Earnings presentation | 09:00 |
| 2026-04-29 | Earnings release - Q1 2026 | |
| 2026-02-04 | Earnings release - Q4 2025 | |
| 2026-02-04 | Earnings presentation | 09:00 |
Past dividends on AbbVie Inc.
| 2026-10-15 | Ex-dividend date - 1.73 USD | 00:00 |
| 2026-07-15 | Ex-dividend date - 1.73 USD | 00:00 |
| 2026-04-15 | Ex-dividend date - 1.73 USD | 00:00 |
| 2026-01-16 | Ex-dividend date - 1.73 USD | 00:00 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 54 318 54 047 0.5% | 56 334 56 043 0.52% | 61 160 60 957 0.33% | 67 809 | 73 853 | 79 653 |
|
EBITDA Million USD | Released Forecast Spread | 25 545 25 858 -1.21% | 24 104 23 980 0.52% | 24 483 24 611 -0.52% | 32 908 | 37 254 | 41 430 |
|
EBIT Million USD | Released Forecast Spread | 24 793 24 926 -0.53% | 23 340 23 323 0.07% | 23 721 23 906 -0.77% | 31 688 | 36 551 | 40 380 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 6 250 8 933 -30.04% | 3 716 10 308 -63.95% | 6 597 11 951 -44.8% | 16 082 | 20 895 | 22 761 |
|
Net income Million USD | Released Forecast Spread | 4 863 8 288 -41.32% | 4 278 3 826 11.8% | 4 226 7 425 -43.08% | 14 820 | 19 100 | 22 384 |
|
EPS USD | Released Forecast Spread | 2,72 5,30 -48.69% | 2,39 2,65 -9.64% | 2,36 3,58 -34.1% | 8,02 | 10,5 | 12,8 |
| Announcement Date | 02/02/24 | 31/01/25 | 04/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 15 102 14 827 1.86% | 13 343 12 921 3.27% | 15 423 15 030 2.61% | 15 776 15 586 1.22% | 16 618 16 415 1.24% | 15 002 14 719 1.93% | 16 990 16 762 1.36% | 17 404 17 347 0.33% | 18 413 | 16 428 | 18 379 | 18 471 | 19 479 |
|
EBITDA Million USD | Released Forecast Spread | 5 447 5 447 0% | 5 829 5 958 -2.16% | 7 019 6 755 3.91% | 5 073 4 864 4.29% | 6 562 6 434 1.99% | 6 315 6 246 1.11% | 8 407 8 299 1.31% | 8 705 | 9 055 | ||||
|
EBIT Million USD | Released Forecast Spread | 5 241 5 246 -0.09% | 5 648 5 499 2.7% | 6 833 6 615 3.3% | 4 881 5 094 -4.18% | 6 359 6 572 -3.24% | 6 127 6 140 -0.22% | 8 213 8 103 1.35% | 8 474 8 447 0.32% | 8 848 | 7 752 | 8 879 | 9 723 | 9 419 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2 269 3 000 -175.63% | 1 661 2 464 -32.59% | 1 554 3 517 -55.81% | 714 4 173 -82.89% | 2 668 4 223 -36.82% | 1 039 3 662 -71.63% | 4 278 5 226 -18.14% | 4 829 5 392 -10.44% | 5 160 | ||||
|
Net income Million USD | Released Forecast Spread | -22,0 -869 97.47% | 1 286 1 778 -27.69% | 938 1 891 -50.41% | 186 -1 149 116.19% | 1 816 5 088 -64.31% | 695 2 827 -75.42% | 3 613 3 715 -2.75% | 4 218 4 286 -1.6% | 6 400 | 3 194 | 4 579 | ||
|
EPS USD | Released Forecast Spread | -0,02 -0,50 95.96% | 0,72 0,29 145.77% | 0,52 1,17 -55.61% | 0,10 -1,19 108.4% | 1,02 2,87 -64.51% | 0,39 1,25 -68.9% | 2,03 1,91 6.25% | 2,37 2,31 2.73% | 2,86 | 1,80 | 2,58 | ||
| Announcement Date | 31/01/25 | 25/04/25 | 31/07/25 | 31/10/25 | 04/02/26 | 29/04/26 | 31/07/26 | 30/10/26 | - | - | - | - | - |
| Today |  | Earnings release - Q2 2027 | |
| Today | | Earnings release - Q2 2027 | |
| Today | | Earnings presentation | 16:30 |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings release - Q3 2026 | |
| Today | | Earnings presentation | 10:00 |
| Today | | Earnings release - Q3 2026 | 01:30 |
| Today | | Earnings presentation | 08:00 |
| Today | | Earnings presentation | 04:00 |
| Today | | Earnings presentation | 08:00 |
Past sector events for AbbVie Inc.
| 2026-11-02 | | Earnings release - Q3 2026 | |
| 2026-11-02 | | Earnings presentation | 16:30 |
| 2026-11-02 | | Earnings presentation | 16:30 |
| 2026-11-02 | | Earnings release - Q3 2026 | 16:00 |
| 2026-11-02 | | Earnings release - Q3 2026 | |
| 2026-11-02 | | Earnings presentation | 16:30 |
| Today | | Board of Directors Meeting | |
| Today | | Board of Directors Meeting | |
| Today | | Board of Directors Meeting | |
| 2026-11-02 | | Earnings presentation | 07:30 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ABBV Stock
- ABBV19 Stock
- Calendar AbbVie Inc.
Select your edition
All financial news and data tailored to specific country editions
